Literature DB >> 1775217

Detection of optic pathway misrouting in the human albino neonate.

P Apkarian1, P G Eckhardt, M J van Schooneveld.   

Abstract

The diagnosis of albinism is indicated by the presence of visual pathway misrouting in which temporal retinal fibers erroneously decussate at the optic chiasm disrupting the normal topographical distribution of retinal geniculate-cortical projections. Detection of misrouted fibers is effected by non-invasive electrophysiological assessment of the topographical representation of the visual evoked potential (VEP) following full field monocular stimulation. By combining appropriate state defined neonatal recording procedures with the albino VEP test paradigm, the presence of aberrant optic pathway projections was detected in a five-day-old full-term infant. The electrophysiological signature pathognomonic to albinism was observed within a long (300 ms) latency window of an otherwise normal neonatal luminance flash response. The results of this study indicate that the VEP misrouting test can be extended to reliable albino diagnosis within the neonatal period.

Entities:  

Mesh:

Year:  1991        PMID: 1775217     DOI: 10.1055/s-2008-1071443

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  3 in total

1.  Genesis, neurotrophin responsiveness, and apoptosis of a pronounced direct connection between the two eyes of the chick embryo: a natural error or a meaningful developmental event?

Authors:  S Thanos
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

2.  Vision in albinism.

Authors:  C G Summers
Journal:  Trans Am Ophthalmol Soc       Date:  1996

3.  Distribution of scotoma pattern related to chiasmal lesions with special reference to anterior junction syndrome.

Authors:  Ulrich Schiefer; Melanie Isbert; Eva Mikolaschek; Ingrid Mildenberger; Elke Krapp; Jan Schiller; Solon Thanos; William Hart
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-04-07       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.